291 related articles for article (PubMed ID: 15280937)
1. Economic cost of community-acquired pneumonia in New Zealand adults.
Scott G; Scott H; Turley M; Baker M
N Z Med J; 2004 Jun; 117(1196):U933. PubMed ID: 15280937
[TBL] [Abstract][Full Text] [Related]
2. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
4. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
[TBL] [Abstract][Full Text] [Related]
5. Economic cost to New Zealand of foodborne infectious disease.
Scott WG; Scott HM; Lake RJ; Baker MG
N Z Med J; 2000 Jul; 113(1113):281-4. PubMed ID: 10935568
[TBL] [Abstract][Full Text] [Related]
6. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
7. Ischaemic stroke in New Zealand: an economic study.
Scott WG; Scott H
N Z Med J; 1994 Nov; 107(989):443-6. PubMed ID: 7970352
[TBL] [Abstract][Full Text] [Related]
8. Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia.
Opmeer BC; El Moussaoui R; Bossuyt PM; Speelman P; Prins JM; de Borgie CA
J Antimicrob Chemother; 2007 Nov; 60(5):1131-6. PubMed ID: 17827142
[TBL] [Abstract][Full Text] [Related]
9. Community acquired pneumonia and direct hospital cost.
Doruk S; Tertemiz KC; Kömüs N; Uçan ES; Kilinç O; Sevinç C
Tuberk Toraks; 2009; 57(1):48-55. PubMed ID: 19533437
[TBL] [Abstract][Full Text] [Related]
10. The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand.
Sheerin IG; Green FT; Sellman JD
Drug Alcohol Rev; 2003 Jun; 22(2):159-67. PubMed ID: 12850902
[TBL] [Abstract][Full Text] [Related]
11. Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.
Asche C; McAdam-Marx C; Seal B; Crookston B; Mullins CD
J Antimicrob Chemother; 2008 May; 61(5):1162-8. PubMed ID: 18310136
[TBL] [Abstract][Full Text] [Related]
12. Costs of nine common mental disorders: implications for curative and preventive psychiatry.
Smit F; Cuijpers P; Oostenbrink J; Batelaan N; de Graaf R; Beekman A
J Ment Health Policy Econ; 2006 Dec; 9(4):193-200. PubMed ID: 17200596
[TBL] [Abstract][Full Text] [Related]
13. The economic burden of prostate cancer, California, 1998.
Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
[TBL] [Abstract][Full Text] [Related]
14. The cost of campylobacteriosis in New Zealand in 1995.
Withington SG; Chambers ST
N Z Med J; 1997 Jun; 110(1046):222-4. PubMed ID: 9236803
[TBL] [Abstract][Full Text] [Related]
15. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
16. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
17. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.
Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G
Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of sexually transmitted infections: incidence and direct medical cost of Chlamydia, gonorrhea, and syphilis among Illinois adolescents and young adults, 2005-2006.
Pultorak E; Wong W; Rabins C; Mehta SD
Sex Transm Dis; 2009 Oct; 36(10):629-36. PubMed ID: 19955874
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden of community-acquired pneumonia among adults in Europe.
Welte T; Torres A; Nathwani D
Thorax; 2012 Jan; 67(1):71-9. PubMed ID: 20729232
[TBL] [Abstract][Full Text] [Related]
20. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
